drugset / Trial / NCT00336531

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

NCT00336531

Phase 4 Completed 100 enrolled Samsung Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to investigate whether the prophylactic use of itraconazole is a better option than empirical use of itraconazole in the management (prevention and treatment) of fungal infection associated with high-dose chemotherapy and autologous hematopoietic stem cell transplantation in children with high-risk solid tumor.

Timeline

Start
2006-04
Primary completion
2008-06
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 2.5 mg/kg